| Cognitive enhancement: methods, ethics, regulatory challenges. | |
| | |
MedLine Citation:
|
PMID: 19543814 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cognitive enhancement takes many and diverse forms. Various methods of cognitive enhancement have implications for the near future. At the same time, these technologies raise a range of ethical issues. For example, they interact with notions of authenticity, the good life, and the role of medicine in our lives. Present and anticipated methods for cognitive enhancement also create challenges for public policy and regulation. |
| | |
Authors:
|
Nick Bostrom; Anders Sandberg |
Related Documents
:
|
17425194 - How technology is reshaping the practice of nongynecologic cytology: frontiers of cytol... 19467394 - Ethical challenges in geriatric care. 12178944 - International migration: new challenges to europe. 6382524 - A search for the ideal society. the assimilation of immigrants into american life. 20136204 - Speech levels in meeting rooms and the probability of speech privacy problems. 18311504 - Cough, basic science, and the clinician. |
Publication Detail:
|
Type: Journal Article Date: 2009-06-19 |
Journal Detail:
|
Title: Science and engineering ethics Volume: 15 ISSN: 1471-5546 ISO Abbreviation: Sci Eng Ethics Publication Date: 2009 Sep |
Date Detail:
|
Created Date: 2009-07-27 Completed Date: 2009-11-03 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9516228 Medline TA: Sci Eng Ethics Country: England |
Other Details:
|
Languages: eng Pagination: 311-41 Citation Subset: E; IM |
Affiliation:
|
Future of Humanity Institute, Faculty of Philosophy & James Martin 21st Century School, Oxford University, Littlegate House, Oxford OX1 1PT, UK. nick.bostrom@philosophy.ox.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Bioethical Issues
/
legislation & jurisprudence Biomedical Enhancement / ethics*, methods* Biomedical Research / ethics*, legislation & jurisprudence Ethics, Research Government Regulation* Humans Nootropic Agents* |
| Chemical | |
Reg. No./Substance:
|
0/Nootropic Agents |
| Comments/Corrections | |
Comment In:
|
Sci Eng Ethics. 2009 Sep;15(3):343-9
[PMID:
19399642
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The effect of the EU Tissues and Cells Directive on bone banking in Denmark: a case study.
Next Document: Periostin localizes to cells in normal skin, but is associated with the extracellular matrix during ...